BioCorRx (BICX) Cash & Current Investments (2010 - 2026)
BioCorRx recorded quarterly Cash & Current Investments of $211911.0 in Q1 2026, up 52.06% quarter-over-quarter from $139360.0 in Q4 2025, and up 777.77% year-over-year from $24142.0 in Q1 2025.
BioCorRx's Cash & Current Investments history runs 17 years deep, the most recent figure standing at $211911.0 for Q1 2026.
- In Q1 2026, Cash & Current Investments rose 777.77% year-over-year to $211911.0; the TTM figure through Mar 2026 stood at $211911.0 (up 777.77% YoY), while the FY2025 annual figure was $139360.0, up 58.3% from the prior year.
- Cash & Current Investments came in at $211911.0 for Q1 2026 at BioCorRx, up from $139360.0 in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $287688.0 in Q3 2025 to a low of $90.0 in Q3 2024.
- A 5-year average of $120702.0 and a median of $111461.0 in 2022 frame the typical range for Cash & Current Investments.
- Across the five-year window, Cash & Current Investments slumped 99.94% in 2024 and soared 319553.33% in 2025, its largest moves.
- BioCorRx's Cash & Current Investments stood at $68615.0 in 2022, then slipped by 4.94% to $65222.0 in 2023, then soared by 34.97% to $88033.0 in 2024, then soared by 58.3% to $139360.0 in 2025, then surged by 52.06% to $211911.0 in 2026.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $211911.0, $139360.0, and $287688.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 84.64 Bn | 87.02 Bn | 16.26 Bn | 940.00 Mn |
| 2 | Tenet Healthcare | 15.22 Bn | 14.39 Bn | 4.41 Bn | 2.97 Bn |
| 3 | Davita | 13.10 Bn | 13.96 Bn | 1.07 Bn | 666.55 Mn |
| 4 | Encompass Health | 10.50 Bn | 11.12 Bn | 1.34 Bn | 163.40 Mn |
| 5 | Ensign | 9.69 Bn | 9.09 Bn | 293.37 Mn | 595.18 Mn |
| 6 | Universal Health Services | 8.92 Bn | 8.88 Bn | 3.21 Bn | 119.03 Mn |
| 7 | Fresenius Medical Care AG | 7.31 Bn | 4.93 Bn | 22,843.10 Bn | 2.38 Bn |
| 8 | Chemed | 5.83 Bn | 5.81 Bn | 215.76 Mn | 16.86 Mn |
| 9 | Pacs | 5.76 Bn | 5.51 Bn | 345.96 Mn | 247.98 Mn |
| 10 | BioCorRx | - | - | 189,355.00 | 211,911.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 211,911.00 |
| Dec 31, 2025 | 139,360.00 |
| Sep 30, 2025 | 287,688.00 |
| Jun 30, 2025 | 111,872.00 |
| Mar 31, 2025 | 24,142.00 |
| Dec 31, 2024 | 88,033.00 |
| Sep 30, 2024 | 90.00 |
| Jun 30, 2024 | 8,365.00 |
| Mar 31, 2024 | 101,080.00 |
| Dec 31, 2023 | 65,222.00 |
| Sep 30, 2023 | 156,409.00 |
| Jun 30, 2023 | 197,304.00 |
| Mar 31, 2023 | 203,687.00 |
| Dec 31, 2022 | 68,615.00 |
| Sep 30, 2022 | 63,529.00 |
| Jun 30, 2022 | 111,461.00 |
| Mar 31, 2022 | 213,166.00 |
| Dec 31, 2021 | 85,838.00 |
| Sep 30, 2021 | 745,457.00 |
| Jun 30, 2021 | 703,158.00 |
| Mar 31, 2021 | 1.91 Mn |
| Dec 31, 2020 | 592,053.00 |
| Sep 30, 2020 | 936,209.00 |
| Jun 30, 2020 | 1.46 Mn |
| Mar 31, 2020 | 1.97 Mn |
| Dec 31, 2019 | 2.65 Mn |
| Sep 30, 2019 | 3.59 Mn |
| Jun 30, 2019 | 4.81 Mn |
| Mar 31, 2019 | 245,373.00 |
| Dec 31, 2018 | 279,772.00 |
| Sep 30, 2018 | 245,373.00 |
| Jun 30, 2018 | 577,010.00 |
| Mar 31, 2018 | 1,807.00 |
| Dec 31, 2017 | 11,342.00 |
| Sep 30, 2017 | 283,541.00 |
| Jun 30, 2017 | 845,067.00 |
| Mar 31, 2017 | 1.68 Mn |
| Dec 31, 2016 | 142,455.00 |
| Sep 30, 2016 | 80,625.00 |
| Jun 30, 2016 | 1.17 Mn |
| Mar 31, 2016 | 121,669.00 |
| Dec 31, 2015 | 220,060.00 |
| Sep 30, 2015 | 8,669.00 |
| Jun 30, 2015 | 127,852.00 |
| Mar 31, 2015 | 21,387.00 |
| Dec 31, 2014 | 53,120.00 |
| Sep 30, 2014 | 8,019.00 |
| Jun 30, 2014 | 320,942.00 |
| Mar 31, 2014 | 128,820.00 |
| Dec 31, 2013 | 108,566.00 |
| Dec 31, 2012 | 6,002.00 |
| Dec 31, 2011 | 1,657.00 |
| Dec 31, 2010 | 7,128.00 |